- Filed
- Nov 12, 2015 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2015 · Nov 12, 2015 | 15.49M sh |
| Shares Diluted | Q3 2015 · Sep 30, 2015 | 15.45M sh |
| Shares Diluted | Q3 2015 · Sep 30, 2015 | 15.36M sh |
| Shares Diluted | Q3 2015 · Sep 30, 2014 | 16.51M sh |
| Shares Diluted | Q3 2015 · Sep 30, 2014 | 16.01M sh |
| Stockholders Equity | Q3 2015 · Sep 30, 2015 | −$207.67K |
| Stockholders Equity | Q3 2015 · Dec 31, 2014 | $63.6K |
| Current Liabilities | Q3 2015 · Sep 30, 2015 | $275.52K |
| Current Liabilities | Q3 2015 · Dec 31, 2014 | $242.21K |
| Total Liabilities | Q3 2015 · Sep 30, 2015 | $301.52K |
| Total Liabilities | Q3 2015 · Dec 31, 2014 | $268.21K |
| Current Assets | Q3 2015 · Sep 30, 2015 | $52.21K |
| Current Assets | Q3 2015 · Dec 31, 2014 | $322.93K |
| Total Assets | Q3 2015 · Sep 30, 2015 | $93.85K |
| Total Assets | Q3 2015 · Dec 31, 2014 | $331.82K |
| Capex | Q3 2015 · Sep 30, 2014 | $7.45K |
| Operating Cash Flow | Q3 2015 · Sep 30, 2014 | −$506.63K |
| Cash And Equivalents | Q3 2015 · Sep 30, 2014 | $386.7K |
| Cash And Equivalents | Q3 2015 · Dec 31, 2013 | $18.99K |
| Sga Expense restated | Q3 2015 · Sep 30, 2014 | $252.17K |
| Sga Expense restated | Q3 2015 · Sep 30, 2014 | $698.43K |
| Rd Expense restated | Q3 2015 · Sep 30, 2014 | $101.81K |
| Rd Expense restated | Q3 2015 · Sep 30, 2014 | $172.92K |
| Net Income | Q3 2015 · Sep 30, 2014 | −$355.51K |
| Net Income | Q3 2015 · Sep 30, 2014 | −$876.36K |
| Operating Income | Q3 2015 · Sep 30, 2014 | −$354.69K |
| Operating Income | Q3 2015 · Sep 30, 2014 | −$873.4K |